skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Inhibition of lipopolysaccharide-stimulated NO production by crotafuran B in RAW 264.7 macrophages involves the blockade of NF-{kappa}B activation through the increase in I{kappa}B{alpha} synthesis

Abstract

Crotafuran B, a natural pterocarpanoid isolated from Crotalaria pallida, inhibited the lipopolysaccharide (LPS)-stimulated nitric oxide (NO) production (IC{sub 5} 16.4 {+-} 0.7 {mu}M) and inducible nitric oxide synthase (iNOS) protein and mRNA expression (IC{sub 5} 11.5 {+-} 0.6 {mu}M and 11.8 {+-} 2.2 {mu}M, respectively), but not via its cytotoxicity or the inhibition of iNOS enzyme activity, in RAW 264.7 macrophages. Crotafuran B also reduced the iNOS promoter activity (IC{sub 5} 13.4 {+-} 0.1 {mu}M) in piNOS-LUC-transfected cells. Crotafuran B treatment inhibited the p65 nuclear translocation and the nuclear factor-{kappa}B (NF-{kappa}B) DNA binding activity in LPS-activated macrophages. Crotafuran B also reduced the NF-{kappa}B transcriptional activity in pNF-{kappa}B-LUC-transfected cells. Crotafuran B had no effect on the LPS-induced phosphorylation of inhibitory {kappa}B{alpha} (I{kappa}B{alpha}), but enhanced the cellular level of I{kappa}B{alpha} that rebounded to the basal levels and increased the I{kappa}B{alpha} mRNA expression. These results indicate that the crotafuran B inhibition of NO production involves a decrease in the iNOS gene expression via the inhibition of NF-{kappa}B activation through the increase in I{kappa}B{alpha} synthesis.

Authors:
 [1];  [2];  [1];  [1];  [3];  [4];  [3];  [5];  [6]
  1. Graduate Institute of Pharmaceutical Chemistry, China Medical University, Taichung, Taiwan (China)
  2. Department of Education and Research, Taichung Veterans General Hospital, 160, Sec. 3, Chung Kang Road, Taichung 407, Taiwan (China)
  3. School of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan (China)
  4. Faculty of Fragrance and Cosmetics, Kaohsiung Medical University, Kaohsiung, Taiwan (China)
  5. Department of Biochemistry, China Medical University, Taichung, Taiwan (China)
  6. Graduate Institute of Pharmaceutical Chemistry, China Medical University, Taichung, Taiwan (China) and Department of Education and Research, Taichung Veterans General Hospital, 160, Sec. 3, Chung Kang Road, Taichung 407, Taiwan (China). E-mail: w1994@vghtc.gov.tw
Publication Date:
OSTI Identifier:
20783407
Resource Type:
Journal Article
Resource Relation:
Journal Name: Toxicology and Applied Pharmacology; Journal Volume: 210; Journal Issue: 1-2; Other Information: DOI: 10.1016/j.taap.2005.07.009; PII: S0041-008X(05)00419-9; Copyright (c) 2005 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA)
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; BIOSYNTHESIS; DNA; ENZYME ACTIVITY; INDIUM OXIDES; INHIBITION; MACROPHAGES; NITRIC OXIDE; PHOSPHORYLATION; PROTEINS; TOXICITY; TRANSLOCATION

Citation Formats

Lin, M.-W., Tsao, L.-T., Huang, L.-J., Kuo, S.-C., Weng, J.-R., Ko, H.-H., Lin, C.-N., Lee, M.-R., and Wang, J.-P.. Inhibition of lipopolysaccharide-stimulated NO production by crotafuran B in RAW 264.7 macrophages involves the blockade of NF-{kappa}B activation through the increase in I{kappa}B{alpha} synthesis. United States: N. p., 2006. Web. doi:10.1016/j.taap.2005.07.009.
Lin, M.-W., Tsao, L.-T., Huang, L.-J., Kuo, S.-C., Weng, J.-R., Ko, H.-H., Lin, C.-N., Lee, M.-R., & Wang, J.-P.. Inhibition of lipopolysaccharide-stimulated NO production by crotafuran B in RAW 264.7 macrophages involves the blockade of NF-{kappa}B activation through the increase in I{kappa}B{alpha} synthesis. United States. doi:10.1016/j.taap.2005.07.009.
Lin, M.-W., Tsao, L.-T., Huang, L.-J., Kuo, S.-C., Weng, J.-R., Ko, H.-H., Lin, C.-N., Lee, M.-R., and Wang, J.-P.. Sun . "Inhibition of lipopolysaccharide-stimulated NO production by crotafuran B in RAW 264.7 macrophages involves the blockade of NF-{kappa}B activation through the increase in I{kappa}B{alpha} synthesis". United States. doi:10.1016/j.taap.2005.07.009.
@article{osti_20783407,
title = {Inhibition of lipopolysaccharide-stimulated NO production by crotafuran B in RAW 264.7 macrophages involves the blockade of NF-{kappa}B activation through the increase in I{kappa}B{alpha} synthesis},
author = {Lin, M.-W. and Tsao, L.-T. and Huang, L.-J. and Kuo, S.-C. and Weng, J.-R. and Ko, H.-H. and Lin, C.-N. and Lee, M.-R. and Wang, J.-P.},
abstractNote = {Crotafuran B, a natural pterocarpanoid isolated from Crotalaria pallida, inhibited the lipopolysaccharide (LPS)-stimulated nitric oxide (NO) production (IC{sub 5} 16.4 {+-} 0.7 {mu}M) and inducible nitric oxide synthase (iNOS) protein and mRNA expression (IC{sub 5} 11.5 {+-} 0.6 {mu}M and 11.8 {+-} 2.2 {mu}M, respectively), but not via its cytotoxicity or the inhibition of iNOS enzyme activity, in RAW 264.7 macrophages. Crotafuran B also reduced the iNOS promoter activity (IC{sub 5} 13.4 {+-} 0.1 {mu}M) in piNOS-LUC-transfected cells. Crotafuran B treatment inhibited the p65 nuclear translocation and the nuclear factor-{kappa}B (NF-{kappa}B) DNA binding activity in LPS-activated macrophages. Crotafuran B also reduced the NF-{kappa}B transcriptional activity in pNF-{kappa}B-LUC-transfected cells. Crotafuran B had no effect on the LPS-induced phosphorylation of inhibitory {kappa}B{alpha} (I{kappa}B{alpha}), but enhanced the cellular level of I{kappa}B{alpha} that rebounded to the basal levels and increased the I{kappa}B{alpha} mRNA expression. These results indicate that the crotafuran B inhibition of NO production involves a decrease in the iNOS gene expression via the inhibition of NF-{kappa}B activation through the increase in I{kappa}B{alpha} synthesis.},
doi = {10.1016/j.taap.2005.07.009},
journal = {Toxicology and Applied Pharmacology},
number = 1-2,
volume = 210,
place = {United States},
year = {Sun Jan 15 00:00:00 EST 2006},
month = {Sun Jan 15 00:00:00 EST 2006}
}